![](/img/cover-not-exists.png)
The cost-utility of aflibercept for the treatment of age-related macular degeneration compared to bevacizumab and ranibizumab and the influence of model parameters
Elshout, Mari, van der Reis, Margriet I., Webers, Carroll A. B., Schouten, Jan S. A. G.Volume:
252
Language:
english
Journal:
Graefe's Archive for Clinical and Experimental Ophthalmology
DOI:
10.1007/s00417-014-2641-3
Date:
December, 2014
File:
PDF, 1.19 MB
english, 2014